slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 219,361-219,390
Pages 10,126
Rows per page 30
Component
219,361-219,390 of 303,780
45
Standard legal disclaimer slide for a SPAC transaction.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank 1 hit
46
Standard risk factor disclosure slide for a SPAC transaction.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank 1 hit
01
Coupang | Results Presentation Deck | 25 slidesCoupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations 1 hit
03
The slide highlights the impact of an FLC accounting change and FX fluctuations on reported revenue growth.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations Beat · Financial PerformanceLoop · Logic Chain1 hit
04
The slide highlights the impact of an accounting change (FLC) and FX fluctuations on revenue growth.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations Beat · Financial PerformanceLoop · Logic Chain1 hit
17
The slide includes a specific note regarding an accounting change for FLC revenue starting in Q2 2023.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations Beat · Market Size and Segment ResultsLoop · Cost Of Inaction1 hit
18
Includes a specific note regarding an accounting change (FLC) impacting revenue growth rates.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations Beat · Market Size and Segment ResultsLoop · Cost Of Inaction1 hit
19
The slide uses a combination of bar charts for revenue and a waterfall-style or negative-bar chart for EBITDA, highlighting margin percentages.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations Beat · Market Size and Segment ResultsLoop · Cost Of Inaction1 hit
20
The slide compares revenue trends and EBITDA margin improvements across five quarters.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations Beat · Market Size and Segment ResultsLoop · Cost Of Inaction1 hit
21
Coupang | Results Presentation Deck | 25 slidesCoupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations Beat · Key Messages and Operating Tenets1 hit
22
The slide uses a lifestyle image of a family using a Coupang delivery bag to reinforce the brand mission.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations 1 hit
23
Financial data in thousands; includes adjustments for depreciation, interest, taxes, and equity-based compensation.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations 1 hit
24
Financial data in thousands of dollars.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations 1 hit
25
The table reconciles Net cash provided by operating activities to Free cash flow by adjusting for capital expenditures and proceeds from asset sales.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations 1 hit
02
The slide uses a grid layout to showcase diverse marketing activities including collaborations, influencer partnerships, and platform launches.Crocs | Investor Presentation Deck | 2 slides · Crocs
Conference presentation Investor relations Beat · Interest1 hit
01
The slide uses a linguistic play on the company name to establish brand identity.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
02
Dense legal text page typical of investor decks; Dare Bio logo top-left, page number '2' bottom-right.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
03
The slide uses a two-column layout to contrast company strengths with market opportunity.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
04
The slide uses a structured list format to categorize assets under Contraception, Vaginal Health, Reproductive Health/Menopause/Sexual Health, and Fertility.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
05
The slide uses a Gantt-style chart to map product development stages against clinical phases.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
06
The slide uses a Gantt-style layout to track drug development progress.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
07
Dare Bioscience | Investor Presentation Deck | 26 slidesDare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations Beat · Solution1 hit
08
The slide uses a comparison to erectile dysfunction to frame the market opportunity.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
The slide uses a yellow underline to emphasize the lack of FDA-approved treatments.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
The slide outlines the methodology and endpoints of a clinical trial.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
11
The slide highlights clinical trial outcomes and regulatory next steps.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
12
The slide serves as a transition or focus slide for the company's lead product.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
13
Includes specific revenue data for Mirena, Lo Loestrin, and NuvaRing as market benchmarks.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations Beat · Market Size1 hit
14
The slide uses a vertical axis to represent effectiveness, positioning the company's proposed solution between existing barrier methods and the Copper IUD.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
15
Includes a quote from a Bayer executive regarding the collaboration.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit